|
HS Code |
796022 |
| Chemical Name | Sialic Acid |
| Molecular Formula | C11H19NO9 |
| Molar Mass | 309.27 g/mol |
| Appearance | White crystalline powder |
| Solubility In Water | Highly soluble |
| Melting Point | 187-191°C |
| Ph | Acidic |
| Storage Conditions | Store in a cool, dry place, protected from light |
| Cas Number | 131-48-6 |
| Purity | Typically >98% |
| Synonyms | N-Acetylneuraminic acid, Neu5Ac |
| Odor | Odorless |
| Stability | Stable under recommended storage conditions |
| Application | Biological research, pharmaceutical intermediate |
| Origin | Commonly found in glycoproteins and glycolipids of animal tissues |
As an accredited Sialic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sialic Acid is packaged in a 25g amber glass bottle with a blue screw cap, labeled with product details and safety information. |
| Shipping | Sialic Acid is shipped in tightly sealed, chemical-resistant containers under cool, dry conditions to prevent degradation. Packaging ensures protection from moisture and light. The shipment complies with relevant regulations for non-hazardous biochemicals, includes appropriate labeling, and is accompanied by safety data sheets. Handle with care to maintain product integrity. |
| Storage | Sialic acid should be stored in a tightly sealed container, protected from light, moisture, and air. It should be kept at -20°C in a dry, cool, and well-ventilated place. Avoid repeated freeze-thaw cycles. Handle under an inert atmosphere if possible to prevent degradation, and label the container clearly. Follow standard laboratory safety procedures when storing and handling. |
| Purity 98%: Sialic Acid with 98% purity is used in pharmaceutical formulations, where it enhances drug bioavailability and efficacy.Molecular Weight 309.27 g/mol: Sialic Acid with a molecular weight of 309.27 g/mol is used in glycoprotein synthesis, where it ensures consistent molecular integration and biological activity.Stability Temperature 4°C: Sialic Acid stable at 4°C is used in diagnostic reagent storage, where it maintains enzymatic activity and assay reliability.Particle Size <50 microns: Sialic Acid with particle size less than 50 microns is used in nutraceutical blends, where it provides improved dispersibility and homogeneous mixing.Endotoxin Level <0.1 EU/mg: Sialic Acid with endotoxin level less than 0.1 EU/mg is used in cell culture media production, where it minimizes contamination risk and supports cell viability.Melting Point 164°C: Sialic Acid with a melting point of 164°C is used in controlled-release tablet manufacturing, where it enables precise thermal processing and stable release profiles.pH 5.5 (1% solution): Sialic Acid at pH 5.5 in 1% solution is used in cosmetic serum formulations, where it promotes skin compatibility and optimizes formulation stability. |
Competitive Sialic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Sialic acid, known in its most common molecular form as N-Acetylneuraminic acid (CAS No. 131-48-6), isn’t just another raw material passing through our reactors. We're dealing with a unique carbohydrate, widely found at the terminal positions of glycoproteins and glycolipids. Behind every consignment we dispatch lies a balance of meticulous process control and experienced handling. The manufacturing of sialic acid at scale means controlling for purity right from the start. We take pride in refining N-Acetylneuraminic acid to at least 98% HPLC purity—anything less doesn't meet the standards that biopharmaceutical, cosmetic, and nutritional segments have come to expect. This isn’t about hitting a spec sheet, but about repeatability batch after batch. Water content, optical rotation, and trace element levels are rigorously managed with calibrated equipment. Our people know that a single percentage point off-target can derail an entire formulation.
Off the line, sialic acid presents itself as a white to off-white crystalline powder, slightly soluble in water. We learned long ago the headaches that excess moisture or metal ions can introduce. Keeping the production area humidity-controlled isn’t just a checklist step—it keeps the product free of hygroscopic clumping and ensures clean handling into bags or drums. Every lot is checked for heavy metals, with results tracing well below international thresholds. Chemists and technicians here understand why low endotoxin levels matter, especially as sialic acid finds its way into injectable drugs or sensitive cell culture media. Our QA chemists regularly run advanced chromatography and spectrometry—not because regulations demand it, but because customer outcomes ultimately depend on that vigilance.
In our experience working with food and pharmaceutical formulators, sialic acid occupies a rare spot as both a functional ingredient and a research compound. Infant formula manufacturers use it to mimic the complex oligosaccharide profile of human breast milk, knowing that the right sialic acid content helps support neural and immune development. In pharma, injectable-grade sialic acid supports glycosylation studies and the synthesis of antiviral agents. Our partners in biologics manufacturing rely on its role in the sialylation of recombinant proteins, a modification that affects the stability and activity of monoclonal antibodies. Cosmetic formulators come to us for sialic acid’s skin-restoring effects, especially in anti-aging products that claim visible benefits. They aren’t just chasing a trend; they need a crystalline product with dependable solubility at room temperature, avoiding the kind of impurity build-up that affects shelf life. You won't get that kind of performance from sialic acid derived from unreliable sources or using shortcuts in purification. Through years of manufacturing, we’ve seen how downstream complaints—cloudy solutions, off-odors, inconsistent reactivity—can be traced back to corners cut at the upstream stage.
Many customers believe all sialic acid is basically the same. They discover otherwise when sourcing from different vendors. On paper, a lot of factories quote the same assay purity or appearance, but not every method of manufacture controls residual solvents, endotoxins, or trace heavy metals to the same standard. Temperature profiles, solvent choices, and filtration steps all leave their signature on the final material. From our vantage point, the decisive difference lies beyond the certificate of analysis. We’ve set up continuous feedback loops between production and customer labs, adjusting our crystallization tempo and refining purification sequences as needed. Some grades intended for regulated markets get extra analytical scrutiny, with batch traceability going down to precursor lot levels. Companies running cell culture media or preclinical trials tell us straight when a sialic acid variant starts throwing off their results. It shows up as aberrant glycoprofiles or stability issues. We've earned their trust by consistently providing transparent impurity mapping and full batch histories—the sort of details you just won’t get when a product changes hands through a maze of traders or bulk resellers.
Manufacturing sialic acid isn’t a hands-off process. It starts with selecting the right microbial strains or synthetic intermediates. Fermentation-based production has moved to the forefront for sustainability. We invest in strain improvement and bioreactor monitoring, knowing that precursor choice shapes not only yields but downstream processing loads. Controlling byproducts during hydrolysis and enzymatic treatment makes a big difference. Any lingering pyruvate or acetic acid can shift product quality outside pharmacopeial bounds. Workers in the plant monitor reaction parameters in real time and flag deviations. Storage and packaging practices also determine how usable sialic acid remains over time. In humid climates, we've had to design improved moisture barrier drums after an incident involving caked and yellowed product. Only after repeated customer complaints did the importance of packaging upgrades hit home. We switched to multi-layered linings and began double-checking seals on every outgoing pallet—costlier, but the shelf-life boost for end-users made it indispensable.
A common question in technical exchanges is how sialic acid compares with other sugars, such as glucosamine or galactose. The distinctions matter for research and application success. Sialic acid stands out due to its 9-carbon backbone and the presence of both amino and carboxyl groups, which give it negative charge and selective binding to proteins and membranes. These structural features mean sialic acid is a terminal residue in glycan chains, directly influencing cellular communication and immune recognition. Swap it out for a simpler monosaccharide, and you lose that specificity. Glycoprotein function shifts, and so does the performance of finished biologics. Formulators building on our sialic acid benefit from robust batch data because they know even trace amounts of isomeric contaminants—something that seldom matters in simpler sugars—can affect downstream pharmacodynamics.
Direct manufacturing builds trust in a way that indirect sourcing cannot match. Our long-time customers ask to see batch records, process change notifications, and even walk the plant. We don’t shy away from that level of scrutiny. Supply chain breakdowns risk formulation failures, regulatory setbacks, and, for some, millions lost to project delays. Our production team communicates anticipated lead times and potential disruption scenarios as soon as we spot them. We take unusual steps for a bulk chemical producer—real-time inventory updating, process updates, and sharing stability data straight from pilot scale batches. This total visibility came after learning the hard way how minor supply hiccups escalate for end-users. Some years back, a temporary raw material shortage hit us mid-cycle, and close customer communication let one research group adjust their project timelines before losing grant funding. We make such transparency routine now. Customers working in regulated sectors insist on upstream-to-downstream visibility, and they deserve that.
Some firms offer discounted sialic acid made with aggressive shortcuts, such as simple precipitation without full purification, or reliance on outdated fermentation control systems. The resulting material might look fine under basic tests, but sub-visible impurities and inconsistent activity soon show up in performance failures. Years of experience taught us that every shortcut in upstream processing or analytical verification costs more in the long run. Customer recalls trace back to these avoidable lapses. Reputational risk for us is not theoretical—the market is quick to judge if a batch triggers out-of-spec product or missed milestones. We take the extra step by sending out stability updates and impurity profiling, not just to clear a regulatory hurdle, but because we have seen firsthand how much is at stake for downstream developers. Once, a single error in trace ion control left a batch unfit for a leading infant formula project. Since then, we practice full batch segregation and intensive in-process controls. No two lots mix unless every parameter lines up.
Customers testing our sialic acid for novel applications always push us to revisit our processes. Maybe a new delivery system or a tighter contaminant threshold drives us to rework chromatographic separation, or fine-tune drying times. Rather than see operational tweaks as burdens, our technical teams treat them as data points to refine manufacturing even further. Collaboration is ongoing. Once, a novel use in wound dressings led our engineers to switch the sequence of crystallization and fluid bed drying, improving powder flow for medical device coating. These practical challenges are more telling than any customer survey—the feedback loops built with R&D partners shape the next generation of our product handling and design.
Environmental responsibility now plays a key role in our factory upgrades. We moved to greener solvents and invested in energy-efficient bioreactors, aiming to minimize our overall carbon footprint. For specialty carbohydrates like sialic acid, sustainable production isn't just about compliance; it's demanded by clients who audit us for lifecycle emissions and end-to-end traceability. Our traceability system tracks every shipment of N-Acetylneuraminic acid back to the precursor stock, providing assurance for those entering regulated markets. The emphasis on data transparency is a reflection of what the field now expects. We no longer see sustainability or traceability as optional checkboxes—they are features that set apart genuine manufacturers from cut-rate brokers.
Drug developers, nutrition scientists, and cosmetic formulators all reach for sialic acid at different stages of research or pilot production. We recognize that our manufacturing choices echo through each of their programs. A stable supply of pharmaceutical-grade sialic acid enables researchers to push the boundaries of glycomics, neurobiology, and immunotherapy. New evidence keeps surfacing about the link between sialic acid levels and neurological development, or how modified sialylation patterns play roles in tumor cell evasion. Researchers investigating these links ask for technical partnership as much as product. Our quality control team works closely with principal investigators to design lots that meet either stringent analytical standards or novel functional assays requested by a scientific journal or regulatory body.
Through decades on the manufacturing line, we learned that every innovation in formulation or delivery begins with a dependable material source. The most exciting advances in medicine or food science start to matter only when all raw ingredients are both reliable and fully traceable. Our perspective is rooted in the day-to-day work of carrying forward best practices. Generation after generation of plant technicians, chemists, and analysts pass down hard-won lessons: never compromise on process validation, always test beyond the minimum, and keep lines of communication open end-to-end. Companies developing tomorrow’s therapies and supplements rely on our diligence because they’ve seen what happens when sialic acid batches fluctuate in grade or stability. Customers aren’t buying just a powder—they’re adopting an entire chain of decisions and experiences that starts with us. We don’t take that responsibility lightly.
Based on what we see every day in manufacturing and supply, buyers seeking sialic acid ought to prioritize direct engagement with the original producer. Technical transparency, batch data, and validated quality controls give the assurance needed for regulated and innovative markets alike. Inquiry into production changes, analytical methods, and batch records pays off when unexpected project variables arise. For critical uses—especially pharmaceuticals, infant nutrition, and cell culture media—choosing an established manufacturer over third-party relabelers provides traceability and timely support. Responding to stability questions or application failures is simpler when feedback flows directly to and from the production team, free from delays or miscommunication that arise within multi-level distribution channels. Prioritize continuous supplier engagement, regular technical dialogue, and willingness to audit processes—the most resilient supply chains depend on more than certificates and packaging. They demand a manufacturer that treats every request and every shipment with the same care and transparency that went into building our own facility’s reputation.
The story of sialic acid does not end with its current applications. Every year, our teams are pulled into new collaborations as medical researchers, food scientists, and pharmacologists shape new roles for this molecule. Gene therapy, new classes of vaccines, synthetic glycomics—each poses unique challenges back to the factory floor. We continue to scale production capacity and integrate modular purification units, designed to respond quickly to specification changes or custom grades. Looking forward, automation and advanced analytics will drive greater consistency and lower contaminants, all while trimming the energy cost and environmental impact of high-volume runs. Customers can expect us at the table not just as suppliers but as experienced partners, ready to walk beside them as sialic acid moves into yet more specialized fields. Every feedback round, inspection, or technical discussion teaches us something new about manufacturing sialic acid with care and responsibility. That experience, earned in practice, is what we bring to every order, every innovation, and every partnership.